Hunan Sundy Science & Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000027Q9
CNY
17.93
0.18 (1.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a growth in Net Profit of 49.6%, the company declared Outstanding results in Sep 25

  • The company has declared positive results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at CNY 221.6 MM
  • NET SALES(HY) At CNY 319.89 MM has Grown at 30.09%
  • ROCE(HY) Highest at 22.47%
2

With ROE of 20.12%, it has a very attractive valuation with a 5.12 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 1,887 Million (Small Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.46%

stock-summary
Debt Equity

-0.47

stock-summary
Return on Equity

20.90%

stock-summary
Price to Book

2.19

Revenue and Profits:
Net Sales:
181 Million
(Quarterly Results - Sep 2025)
Net Profit:
54 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.9%
0%
-9.9%
6 Months
-12.28%
0%
-12.28%
1 Year
7.56%
0%
7.56%
2 Years
90.54%
0%
90.54%
3 Years
13.12%
0%
13.12%
4 Years
69.79%
0%
69.79%
5 Years
85.23%
0%
85.23%

Hunan Sundy Science & Technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
16.04%
EBIT Growth (5y)
33.47%
EBIT to Interest (avg)
72.62
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.66
Tax Ratio
9.49%
Dividend Payout Ratio
42.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.57%
ROE (avg)
13.48%

Valuation key factors

Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
5.12
EV to EBIT
25.34
EV to EBITDA
23.28
EV to Capital Employed
7.42
EV to Sales
6.10
PEG Ratio
0.15
Dividend Yield
0.67%
ROCE (Latest)
29.30%
ROE (Latest)
20.12%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 18.99% vs 0.59% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 48.22% vs 125.31% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "181.10",
          "val2": "152.20",
          "chgp": "18.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "47.50",
          "val2": "37.00",
          "chgp": "28.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.30",
          "val2": "3.20",
          "chgp": "3.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "54.10",
          "val2": "36.50",
          "chgp": "48.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "262.20%",
          "val2": "213.60%",
          "chgp": "4.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 24.30% vs 17.95% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 163.14% vs -43.68% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "571.80",
          "val2": "460.00",
          "chgp": "24.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "166.20",
          "val2": "50.80",
          "chgp": "227.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "144.20",
          "val2": "54.80",
          "chgp": "163.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "259.60%",
          "val2": "77.00%",
          "chgp": "18.26%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
181.10
152.20
18.99%
Operating Profit (PBDIT) excl Other Income
47.50
37.00
28.38%
Interest
0.00
0.00
Exceptional Items
3.30
3.20
3.13%
Consolidate Net Profit
54.10
36.50
48.22%
Operating Profit Margin (Excl OI)
262.20%
213.60%
4.86%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 18.99% vs 0.59% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 48.22% vs 125.31% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
571.80
460.00
24.30%
Operating Profit (PBDIT) excl Other Income
166.20
50.80
227.17%
Interest
0.20
0.20
Exceptional Items
0.40
0.00
Consolidate Net Profit
144.20
54.80
163.14%
Operating Profit Margin (Excl OI)
259.60%
77.00%
18.26%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 24.30% vs 17.95% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 163.14% vs -43.68% in Dec 2023

stock-summaryCompany CV
About Hunan Sundy Science & Technology Co., Ltd. stock-summary
stock-summary
Hunan Sundy Science & Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available